Latest AI and machine learning research in other cancers for healthcare professionals.
Neoadjuvant therapy (NAT) has demonstrated considerable effectiveness in treating locally advanced non-small cell lung cancer (NSCLC). Major pathological response (MPR), defined by the proportion of viable tumor cells in the tumor bed assessed through whole slide images (WSIs), is regarded as a crucial marker for predicting patient prognosis. While artificial intelligence (AI)-assisted WSI analysi...
Artificial intelligence (AI) is rapidly transforming the management landscape of inflammatory bowel disease (IBD). While early applications in endoscopy, digital pathology and cross-sectional imaging drew substantial attention, next-generation AI systems that enable deeper disease understanding, personalized treatment and streamlined clinical workflows are now emerging. These advances encompass th...
BACKGROUND: Skin cancer is one of the most prevalent cancers globally, with early detection critical to ensure reduced mortality risk. To aid early de...
BACKGROUND: Breast phyllodes tumours (PT) are rare biphasic neoplasms consisting of epithelial and stromal components. They are classified into benign...
BACKGROUND: International guidelines recommend 5FU/LV, Nal-IRI + 5FU/LV, FOLFIRI, FOLFOX, or (m)FOLFIRINOX as second-line (2 L) chemotherapy for patie...
177Lu-PSMA-targeted radioligand therapy (TRT) represents a major advance in managing metastatic castration-resistant prostate cancer (mCRPC), exploiti...
The primary leading reason for cancer death is non-small-cell lung cancer (NSCLC) still up to date globally. Even with today's advanced technology, it...
Antibody-drug conjugates (ADCs) are a leading area of targeted cancer therapeutics, typically combining a tumour-associated antigen-specific antibody ...
BACKGROUND: Survival outcomes after transarterial chemoembolisation (TACE) vary in hepatocellular carcinoma (HCC) patients, and existing prognostic sc...
Whole-body MRI (WB-MRI) has evolved over the past 2 decades as a noninvasive imaging technique for detecting distant metastases in prostate cancer. Si...
Hepatocellular carcinoma (HCC) exhibits marked sexual dimorphism, with females demonstrating superior survival, yet the underlying molecular mechanism...
Pancreatic cancer is highly aggressive with poor outcomes; current artificial intelligence (AI) prognostic models often lack interpretability and unde...
The advancement of mRNA technology has rejuvenated the cancer treatment immunotherapy field by providing a flexible and scalable platform to generate ...
Although immunotherapy has revolutionized cancer treatment, many patients still experience limited benefit, highlighting the urgent need for improved ...
BACKGROUND: After resection surgery, recurrence occurs in more than 30% of colorectal cancer (CRC) patients. Previous studies have highlighted the rol...
OBJECTIVE: To define oncologic outcomes in Veterans in the modern era using a multi-institutional cohort designed to support development and validatio...
IMPORTANCE: Cancer antigen 19-9 (CA19-9) is used to assess treatment response among patients with pancreatic ductal adenocarcinoma (PDAC); however, ne...
BACKGROUND: Over the past decade, machine learning (ML) has transformed histopathology, yet its application in lupus nephritis (LN) remains underexplo...